Rio Rancho Center: Psych Drugs Given Without Consent - NM
The facility's own Director of Nursing told inspectors that every one of those residents should have had a signed consent form before any psychotropic medication was administered. None of them did.
The drugs involved were not minor. One resident, identified in inspection records as Resident 1, received Clonazepam, a controlled benzodiazepine used for anxiety, and Haloperidol, an antipsychotic that in this case was ordered as an intramuscular injection of 2 milligrams every six hours for agitation and combativeness. Haloperidol carries a well-documented risk of serious side effects, including involuntary muscle movements that can become permanent. The consent form that should have preceded that injection was never completed.
A second resident, Resident 2, received a cascade of psychotherapeutic drugs over a matter of weeks. Clonazepam. Haloperidol. Hydroxyzine, an antihistamine also used to treat anxiety. Ramelteon, a sedative for insomnia. And Risperidone, another antipsychotic, ordered at 0.25 milligrams every eight hours for agitation and given for the duration of a 14-day course before being discontinued on March 23. Inspectors reviewed this resident's electronic health record on the day of the inspection and found no completed consent form for any of those medications.
Resident 5 had been living at the facility since January 2023, more than three years. Their diagnoses included Parkinsonism, dementia with behavioral disturbance, major depressive disorder, and hallucinations. They had been receiving Caplyta, an antipsychotic used as an add-on treatment for depression, and Mirtazapine, an antidepressant, since December 31, 2025. Both were discontinued on April 23, then immediately reordered the same day under fresh physician orders. As of April 27, the date inspectors arrived, no consent form had ever been completed for either drug.
Resident 6 was admitted February 14, 2026, with diagnoses of depression and panic disorder. By March 20, they had a standing order for Clonazepam twice daily. By April 13, they had been prescribed Olanzapine, an antipsychotic, 10 milligrams at bedtime for psychosis. No consent form existed for either medication.
The Director of Nursing did not dispute any of it. During an interview at 2:33 in the afternoon on the day of the inspection, she said her expectation was that all residents, or their representatives, receive information about treatments and medications before those treatments begin, so they understand both the risks and the benefits. She confirmed that Residents 1, 2, 5, and 6 should have had completed and signed consent forms. She could not point inspectors to any.
Psychotropic medications carry real consequences for elderly patients, particularly those with dementia or movement disorders. Antipsychotics prescribed to dementia patients carry a black-box warning for increased risk of death. Benzodiazepines like Clonazepam increase fall risk. Consent forms exist precisely because these are not routine decisions, and because residents and their families have a right to weigh in before powerful drugs that alter brain chemistry are introduced.
At Rio Rancho Center, that process broke down for at least four people across a span of months. Resident 5 had been receiving medications without documented consent since at least December 31 of last year. The facility had time, and didn't act.
The Director of Nursing knew what the standard was. She stated it plainly to inspectors. What she could not explain was why, for these four residents, it was never met.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Rio Rancho Center from 2026-04-27 including all violations, facility responses, and corrective action plans.
Download the official CMS inspection PDF from Medicare.gov
Additional Resources
Data source: This article is based on inspection data downloaded directly from the Centers for Medicare & Medicaid Services (CMS) via Medicare.gov. CMS releases inspection reports in bulk; we publish the findings as documented by state surveyors in the official Form CMS-2567 Statement of Deficiencies.
Plan of correction: The CMS report we receive does not include the facility's plan of correction. Facilities submit plans of correction separately to state survey agencies and those responses may not be reflected in CMS data at the time of publication. The absence of a plan of correction in our data does not mean one was not filed. Readers who want information about corrective steps taken are encouraged to contact the facility directly or their state survey agency.
Corrections may have occurred: Inspection reports reflect conditions observed on the date of the survey. Facilities may have implemented corrections, staffing changes, additional training, or other remediation since the report was issued. We report what CMS provides and encourage readers to seek current information from the facility.
Editorial process: Inspection findings are extracted from CMS source documents and synthesized using AI, reviewed for factual accuracy against the original report by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: September 19, 2026 · Our methodology
Rio Rancho Center in Rio Rancho, NM was cited for violations during a health inspection on April 27, 2026.
The drugs involved were not minor.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.